hotspot -WSS

hotspot

author：fashion 2025-09-29 21:13:40 - browse：7

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Why Marc Tessier

entertainment

WSS

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

A former Republican legislative candidate has been charged for his role in the US Capitol riot

How Brent Saunders' Allergan experiment failed

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

At least 12 people were injured in a blast at a port in northwest Turkey

What is the Turing Test that determines if computers can think?

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Apple is now the first public company to be valued at $3 trillion

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Psychedelics group wrestles with new pharma identity

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

As demand for Covid shots wanes, Moderna seeks its next success

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

knowledge

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

'The Exorcist' director William Friedkin dead at 87

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Mississippi candidates for statewide offices square off in party primaries

entertainment

Wikipedia

Wikipedia

focus